PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
-0.56%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$15.7M
AUM Growth
-$1.33M
(-7.8%)
Cap. Flow
-$983K
Cap. Flow
% of AUM
-6.27%
Top 10 Holdings %
Top 10 Hldgs %
39.89%
Holding
471
New
38
Increased
139
Reduced
174
Closed
55
Top Buys
| 1 |
DexCom
DXCM
|
$67.2K |
| 2 |
Penumbra
PEN
|
$64.7K |
| 3 |
Meta Platforms (Facebook)
META
|
$55.7K |
| 4 |
Becton Dickinson
BDX
|
$55.2K |
| 5 |
GitLab
GTLB
|
$51.5K |
Top Sells
| 1 |
Ferguson
FERG
|
$877K |
| 2 |
Adobe
ADBE
|
$85.2K |
| 3 |
Steris
STE
|
$78.2K |
| 4 |
Neurocrine Biosciences
NBIX
|
$64.8K |
| 5 |
CVS Health
CVS
|
$62.9K |
Sector Composition
| 1 | Technology | 30.09% |
| 2 | Industrials | 22.23% |
| 3 | Healthcare | 19.2% |
| 4 | Financials | 15.68% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Teradyne
TER
$19B
| $48.4K | 0.31% |
+643,544
| New | +$48.4K |
|
77
Roblox
RBLX
$90.2B
| $47.2K | 0.3% |
1,317,304
-91,602
| -7% | -$3.28K |
|
78
Ryan Specialty Holdings
RYAN
$7.01B
| $46.7K | 0.3% |
1,150,000
| – | – |
|
79
FIVE9
FIVN
$2.01B
| $46K | 0.29% |
613,336
-605,412
| -50% | -$45.4K |
|
80
Avantor
AVTR
$8.91B
| $44.9K | 0.29% |
2,292,272
+274,094
| +14% | +$5.37K |
|
81
Tenable Holdings
TENB
$3.65B
| $44.3K | 0.28% |
1,272,013
-202,646
| -14% | -$7.05K |
|
82
Micron Technology
MU
$137B
| $44.1K | 0.28% |
880,679
-768,983
| -47% | -$38.5K |
|
83
AbbVie
ABBV
$375B
| $44.1K | 0.28% |
328,510
+45,718
| +16% | +$6.14K |
|
84
Freshworks
FRSH
$3.76B
| $43.9K | 0.28% |
3,383,977
+2,009,264
| +146% | +$26.1K |
|
85
Bio-Rad Laboratories Class A
BIO
$7.81B
| $43.2K | 0.28% |
103,654
-11,405
| -10% | -$4.76K |
|
86
Globus Medical
GMED
$8.12B
| $43.2K | 0.28% |
725,308
+11,960
| +2% | +$712 |
|
87
Legend Biotech
LEGN
$6.45B
| $43K | 0.27% |
1,054,017
+479,930
| +84% | +$19.6K |
|
88
Trupanion
TRUP
$1.93B
| $42.2K | 0.27% |
710,000
+10,000
| +1% | +$594 |
|
89
Celldex Therapeutics
CLDX
$1.51B
| $40.7K | 0.26% |
1,448,934
+801,514
| +124% | +$22.5K |
|
90
ProAssurance
PRA
$1.22B
| $39.8K | 0.25% |
2,037,500
+87,500
| +4% | +$1.71K |
|
91
AngioDynamics
ANGO
$432M
| $38.3K | 0.24% |
1,872,236
| – | – |
|
92
Sanofi
SNY
$111B
| $38K | 0.24% |
1,000,000
+275,000
| +38% | +$10.5K |
|
|
BLU
93
DELISTED
BELLUS Health Inc.
BLU
| $37.4K | 0.24% |
3,537,225
+37,225
| +1% | +$393 |
|
94
Eli Lilly
LLY
$668B
| $36.6K | 0.23% |
113,138
+74,144
| +190% | +$24K |
|
95
Y-mAbs Therapeutics
YMAB
$389M
| $36.5K | 0.23% |
2,531,546
-421,125
| -14% | -$6.07K |
|
96
LivaNova
LIVN
$3.14B
| $35.2K | 0.22% |
693,832
+20,128
| +3% | +$1.02K |
|
|
MYOV
97
DELISTED
Myovant Sciences Ltd.
MYOV
| $35K | 0.22% |
+1,947,906
| New | +$35K |
|
|
ISEE
98
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $33.5K | 0.21% |
1,868,628
| – | – |
|
99
Addus HomeCare
ADUS
$2.04B
| $33K | 0.21% |
346,297
| – | – |
|
|
NSTG
100
DELISTED
NanoString Technologies, Inc.
NSTG
| $32.9K | 0.21% |
2,576,357
+550,188
| +27% | +$7.03K |
|